IntriCon Corporation (IIN): Price and Financial Metrics
GET POWR RATINGS... FREE!
IIN Price/Volume Stats
Current price | $24.24 | 52-week high | $25.15 |
Prev. close | $24.23 | 52-week low | $12.47 |
Day low | $24.24 | Volume | 94,300 |
Day high | $24.25 | Avg. volume | 105,292 |
50-day MA | $23.95 | Dividend yield | N/A |
200-day MA | $19.67 | Market Cap | 225.48M |
IIN Stock Price Chart Interactive Chart >
IntriCon Corporation (IIN) Company Bio
IntriCon Corporation designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets. The company also provides medical and micro coils for pacemaker programming and interventional catheter positioning applications; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear-and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. IntriCon Corporation was formerly known as Selas Corporation of America. The company was founded in 1930 and is based in Arden Hills, Minnesota.
Latest IIN News From Around the Web
Below are the latest news stories about INTRICON CORP that investors may wish to consider to help them evaluate IIN as an investment opportunity.
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates IIN, VEC, SWM, BFCNEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: IntriCon Corporation (NASDAQ: IIN )''s sale to an affiliate of Altaris Capital Partners, LLC for $24.25 per share. If you are an IntriCon shareholder, click here to learn more about your rights and options . Vectrus, Inc. (NYSE: VEC )''s merger with The Vertex Company. If you are a Vectrus shareholder, click here to learn more about … Full story available on Benzinga.com |
TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?TTDKY vs. IIN: Which Stock Is the Better Value Option? |
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates VEC, IIN, WLL, OASNEW YORK, March 22, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Vectrus, Inc. (NYSE: VEC )''s merger with The Vertex Company. If you are a Vectrus shareholder, click here to learn more about your rights and options . IntriCon Corporation (NASDAQ: IIN )''s sale to an affiliate of Altaris Capital Partners, LLC for $24.25 per share. If you are an IntriCon shareholder, Full story available on Benzinga.com |
INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IINNEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intricon Corporation (NasdaqGM: IIN) to an affiliate of Altaris Capital Partners, LLC. Under the terms of the proposed transaction, shareholders of Intricon will receive only $24.25 in cash for each share of Intricon that they own. KSF is seeking to determine whether this consideration and the process that led |
Colliers Securities Downgrades Intricon (IIN) to HoldColliers Securities analyst Kyle Bauser downgraded Intricon (IIN – Research Report) to Hold today. The company's shares closed last Monday at $23.93. According to TipRanks.com, Bauser is ranked 0 out of 5 stars with an average return of -6.4% and a 34.7% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Chembio Diagnostics, and Semler Scientific. Intricon has an analyst consensus of Moderate Buy, with a price target consensus of $25.00. See today’s best-performing stocks on TipRanks >> The company has a one-year high of $28.16 and a one-year low of $12.47. Currently, Intricon has an average volume of 28.81K. |
IIN Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | 71.43% |
5-year | -22.56% |
YTD | N/A |
2022 | 0.00% |
2021 | -10.66% |
2020 | 0.56% |
2019 | -31.77% |
2018 | 33.23% |
Continue Researching IIN
Here are a few links from around the web to help you further your research on Intricon Corp's stock as an investment opportunity:Intricon Corp (IIN) Stock Price | Nasdaq
Intricon Corp (IIN) Stock Quote, History and News - Yahoo Finance
Intricon Corp (IIN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...